June 29, 2022 — Siemens Healthineers and The Ohio State University Wexner Medical Center announced a new alliance, aimed ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
June 22, 2022 — Andrei Iagaru, MD, FACNM, professor of radiology (nuclear medicine) and chief of the Division of Nuclear ...
June 21, 2022 — Markus Schwaiger, MD, a scientist known for his contributions to cardiac PET imaging, has been named as ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
June 15, 2022 — Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI ...
June 15, 2022 — Patients with severe obstructive sleep apnea (OSA) are less able to increase blood flow to the heart ...
June 15, 2022 — Current guidelines used to plan salvage radiation treatments in patients with local recurrence of ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
June 14, 2022 — A novel artificial intelligence method can be used to generate high-quality “PET/CT” images and ...
June 10, 2022 — GE Healthcare provides cutting-edge molecular imaging solutions that enable and increase access to ...
The "Mobile Imaging Services - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
June 8, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...
The "Nuclear Medicine Market Size, Share & Trends Analysis Report by Product (Diagnostics (SPECT, PET)), Therapeutics ...
May 16, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
May 13, 2022 — The ACR Committee on Drugs and Contrast Media, within the ACR Commission on Quality and Safety, is aware ...
May 10, 2022 — At the ISMRM 2022 conference, Bruker announced the launch of innovative 7 Tesla and 9.4 Tesla conduction ...
May 4, 2022 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) ...
April 15, 2022 — Prostate cancer is the most common malignant tumor in men in Germany, with about 62,000 new cases ...
April 11, 2022 — A novel nuclear medicine combination therapy has been proven safe and effective in men with heavily pre ...
April 8, 2022 — The Centers for Medicare & Medicaid Services (CMS) released a national policy for coverage of aducanumab ...
March 29, 2022 — GE Healthcare announced the first patient dosed in the Phase III clinical trial for a Positron Emission ...
March 23, 2022 — A significant number of COVID-19 neurological complications— such as fatigue, headache, and cognitive ...